Latest Breaking News On - Matthewk fust - Page 1 : comparemela.com

Ultragenyx Pharmaceutical (NASDAQ:RARE) PT Raised to $115 00

Ultragenyx Pharmaceutical (NASDAQ:RARE) PT Raised to $115 00
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesStifel nicolausThomas richard kassbergMatthewk fustJpmorgan chase coAssociates corpCovestor ltdCantor fitzgeraldCanaccord genuity groupSecurities exchange commissionUltragenyx pharmaceutical incHeadlands technologiesUltragenyx pharmaceuticalGet free reportRichard kassbergExchange commission

Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target Raised to $111 00 at Canaccord Genuity Group

Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target Raised to $111 00 at Canaccord Genuity Group
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesRobertw bairdDekabank deutsche girozentraleMatthewk fustThomas richard kassbergFranklin resources incCanaccord genuity groupCantor fitzgeraldSecurities exchange commissionRoyal bankUltragenyx pharmaceutical company profileJpmorgan chase coYork state common retirement fundCharles schwab investment management incUltragenyx pharmaceutical inc

Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target Cut to $76 00

Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target Cut to $76 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesThomas richard kassbergMatthewk fustStifel nicolausRobertw bairdCanaccord genuity groupJump financialSwiss national bankPrincipal financial group incBarclays plcSecurities exchange commissionUltragenyx pharmaceutical incUltragenyx pharmaceuticalGet free reportDirector matthewExchange commission

Pier 88 Investment Partners LLC Acquires 8,910 Shares of Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

Pier 88 Investment Partners LLC grew its stake in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 76.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,590 shares of the biopharmaceutical company’s stock after acquiring an additional 8,910 shares during the […]

United statesKarah herdman parschauerRobertw bairdMatthewk fustAssociates corpInvestment partnersInternational assets investment managementJpmorgan chase coCovestor ltdRoyal bankAllspring global investments holdingsCanaccord genuity groupUltragenyx pharmaceutical incExchange commissionUltragenyx pharmaceutical company profileCantor fitzgerald

Crinetics Pharmaceuticals (NASDAQ:CRNX) Rating Reiterated by JMP Securities

Crinetics Pharmaceuticals (NASDAQ:CRNX) Rating Reiterated by JMP Securities
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Matthewk fustPiper sandlerDana pizzutiCrinetics pharmaceuticalsVanguard group incJennison associatesNews ratings for crinetics pharmaceuticals dailyMorgan stanleyAnalyst recommendations for crinetics pharmaceuticalsCrinetics pharmaceuticals stock performanceCantor fitzgeraldSecurities exchange commissionEventide asset managementInstitutional investors weigh in on crinetics pharmaceuticalsInsider transactions at crinetics pharmaceuticalsCrinetics pharmaceuticals inc